ArticleCureus2026
Improvement in Domestic Violence and Aggression in Comorbid ADHD and Conduct Disorder Following Methylphenidate Initiation: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Attention-deficit hyperactivity disorder (ADHD) and conduct disorder (CD) are diagnoses that are frequently comorbid. CD is characterised by persistent dissocial, aggressive, and defiant behaviors that defy age-appropriate expectations. This is the case of a 15-year-old male adoptee referred to Tier 3 Child and Adolescent Mental Health Service (CAMHS) for severe aggression, impulsivity, and domestic violence. The patient exhibited coercive control toward his mother, physical violence involving weapons, and property damage, necessitating police involvement and risking family placement breakdown. Following a failure of psychosocial interventions, the patient underwent the Quantified Behavioral (Qb) Test and Conners-4 assessments and review by a consultant psychiatrist confirming ADHD and conduct disorder diagnosis. Methylphenidate was initiated and titrated to 36mg daily. Outcomes were significant. Within one month, antisocial behaviors reduced markedly. At seven months, domestic violence had ceased, and social care involvement ended. The patient successfully completed his General Certificates of Secondary Education (GCSE). Repeat testing on medication showed normalisation of scores: QbTest activity dropped to the 23rd percentile and impulsivity to the 21st percentile. Crucially, parent-rated Conners-4 scores for CD dropped to zero. This case highlights the importance of identifying and treating underlying ADHD in adolescents presenting with severe conduct issues. Higher doses of methylphenidate are often cited as beneficial for CD symptom reduction; this patient achieved remission of aggression at 36mg/day. The case shows that delaying ADHD diagnosis in favor of solely managing behavioral conduct symptoms can risk education and family stability. Treating the ADHD effectively mitigated the emotional dysregulation and violence and reduced the negative impact on this patient during a crucial period of his life as he was completing high school. This case highlights the importance of considering comorbid ADHD and CD in patients presenting with impulsive behaviours and aggression as their primary presenting complaints. Appropriate management with methylphenidate could have a significant therapeutic effect on these patients and their antisocial behaviours.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.